Mycophenolate mofetil and Androgel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mycophenolate mofetil and Androgel. Common interactions include hypertension among males.

The phase IV clinical study analyzes what interactions people who take Mycophenolate mofetil and Androgel have. It is created by eHealthMe based on reports of 9 people who take Mycophenolate mofetil and Androgel from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Feb, 02, 2023

9 people who take Mycophenolate mofetil and Androgel together, and have interactions are studied.


What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 73,759 Mycophenolate mofetil users for its effectiveness, alternative drugs and more.

What is Androgel?

Androgel has active ingredients of testosterone. It is often used in testosterone. eHealthMe is studying from 25,177 Androgel users for its effectiveness, alternative drugs and more.

Number of Mycophenolate mofetil and Androgel reports submitted per year:

Mycophenolate mofetil and Androgel drug interactions.

Common Mycophenolate Mofetil and Androgel drug interactions by gender *:

female:

n/a

male:

  1. Hypertension
  2. Decreased appetite
  3. Arrhythmia
  4. Blood creatinine increased
  5. Blood glucose increased
  6. Bowel movement irregularity
  7. Cardiac arrest
  8. Colitis ulcerative
  9. Crohn's disease
  10. Depressed mood

Common Mycophenolate Mofetil and Androgel drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Colitis ulcerative
  2. Crohn's disease
  3. Depressed mood
  4. Diabetes mellitus
  5. Gastrointestinal haemorrhage
  6. Graft versus host disease
  7. Hypertension
  8. Myopathy
  9. Oesophageal ulcer
  10. Colitis

30-39:

n/a

40-49:

  1. Hiatus hernia
  2. Liver disorder
  3. Lymphadenopathy
  4. Squamous cell carcinoma

50-59:

  1. Chronic kidney disease
  2. Emotional distress
  3. Nephropathy
  4. Pain
  5. Renal failure
  6. Somnolence

60+:

  1. Asthenia
  2. Cough
  3. Bowel movement irregularity
  4. Cardiac arrest
  5. Chronic kidney disease
  6. Decreased appetite
  7. Diarrhoea
  8. Dyspnoea
  9. Failure to thrive
  10. Fall

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and Androgel?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Mycophenolate mofetil and Androgel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Mycophenolate mofetil side effects:

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Androgel side effects:

Browse all side effects of Androgel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Mycophenolate mofetil interactions:

Browse all interactions between Mycophenolate mofetil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Androgel interactions:

Browse all interactions between Androgel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil and testosterone (the active ingredients of Mycophenolate mofetil and Androgel, respectively), and Mycophenolate mofetil and Androgel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Mycophenolate mofetil and Androgel.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: